Lu Jun

2023.8,,; 2025.2-2025.8,,; 2025.6 、 、 、 、 、 、; 2022.8-2023.7,,; 2019.08-2022.06 /,, 2016.08-2019.06 /,, 2013.07-2016.06 /,, 2008.09-2013.06 /,,: 、 、, 、 ( 863 )、 、 、 、 、, ( C ) 1,, 1, 2.: 《 》 《 Oncology and Translational Medicine 》 《 Advanced Clinical Engineering 》 《 Surgical Technology International 》: ( 2025 ) 2025 Rising Star “ ” 2023 “ ” “ ” 2018 - - “ ” “ ” /: 1. Lu J #, Li L #, Chen Q #, Li B Q, Ren S Q, Yuan M, Meng M, Lei J A, Bing Y T, Wang H Y, Ma Z L, Xiu D R, Yuan C H *. Expression and prognostic significance of MLH1 and GPRC5C in resectable hepatocellular carcinoma. BMC Cancer. 2025;25(1):1215. 2. Lu J #, Li L #, Chen Q #, Li B, Ren S, Yuan M, Meng M, Lei J, Bing Y, Wang H, Guo L, Ma Z, Xiu D, Yuan C *. Clinicopathologic and prognostic significance of TIAM2 overexpression in resected hepatocellular carcinoma. Future Sci OA. 2025;11(1):2582439. 3. Lu J #, Zhou L #, Yang G #, Liang Z Y, Zhou W X, You L, Yuan D, Li B Q, Guo J C *, Zhao Y P *, Clinicopathologic and prognostic significance of MKK4 and MKK7 in resectable pancreatic ductal adenocarcinoma. Hum Pathol.2019.86:143-154. 4. Chen Q #, Ren S #, Lu J #, Meng M, Zhang T, Chen H W, Yang L D, Meng C, Bing Y T *, Li L *, Yuan C H *. Contrastive Swin Transformer With Masked Autoencoder for Pancreatic Cancer Computed Tomography Image Classification in the Internet of Medical Things[J]. IEEE Internet of Things Journal, 13. 5. Chen, Q #, Ren S #, Lu J #, Meng M, Zhang T, Chen H W, Yang L D, Meng C, Bing Y T *, Li L *, Yuan C H *. A simclr-based contrastive swin-unet model for pancreas segmentation in the internet of medical things. IEEE Internet of Things Journal. 6. Liu WJ #, Lu J #, Zhou WX, Liu JZ, Zhou L *. MLH1 Inhibits Metastatic Potential of Pancreatic Ductal Adenocarcinoma via Downregulation of GPRC5C. Lab Invest. 2024;104(9):102107. 7. Zhou L #, Lu J #, Liang Z Y, Zhou W X, Yuan D, Li B Q, You L, Guo J C *, Zhao Y P *, High nuclear Survivin expression as a poor prognostic marker in pancreatic ductal adenocarcinoma. J Surg Oncol.2018.118(7):1115-1121. 8. Zhang X #, Lu J #, Zhou L, You L, Liang Z Y, Guo J C *, Zhao Y P *. Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma. Pancreas. 2020;49(6):812-821. 9. Zhou L #, Lu J #, Liang Z Y, Zhou W X, Wang Y Z, Jiang B L, You L, Guo J C *. Expression and Prognostic Value of Small Mothers Against Decapentaplegic 7, Matrix Metalloproteinase 2, and Matrix Metalloproteinase 9 in Resectable Pancreatic Ductal Adenocarcinoma. Pancreas. 2021;50(8):1195-1201. 10. Zhou L #, Lu J #, Liang ZY, Zhou WX, Jiang BL, Wang YZ, Liu CX, Huang BW, You L, Guo JC *. FGFR3 Nuclear Translocation Contributes to Proliferative Potential and Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Pancreas. 2022;51(5):476-482. 11. #,,, *..,2018,35(8):1393-13. 12. * #..,2020,3(3):178-179.: (1); (2); (3); (4) 、; (5).